Sugi Predict

Sugi Predict / Compounds / SCHEMBL798074

SCHEMBL798074

SCHEMBL798074

O=S(=O)(NS(=O)(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.64
▸ CA2 P00918 2/20 0.64
▸ MMP1 P03956 1/20 0.64
▸ MMP2 P08253 1/20 0.64
▸ MMP9 P14780 1/20 0.64
▸ MMP8 P22894 1/20 0.64
▸ MMP13 P45452 1/20 0.64
▸ KEAP1 Q14145 3/20 0.61
▸ IL1RN P18510 1/20 0.61
▸ ERAP1 Q9NZ08 1/20 0.61
▸ ALDH1A1 P00352 4/20 0.56
▸ PKM P14618 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ HTR6 P50406 1/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ GBA1 P04062 1/20 0.54
▸ BCAT1 P54687 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29653769 1.00 CA1 (0.64) CA1CA2MMP1MMP2MMP9
Fluoride SCHEMBL28175459 0.97 CA1 (0.61) CA1CA2MMP1MMP2MMP9
SCHEMBL29011157 0.97 CA1 (0.61) CA1CA2MMP1MMP2MMP9
Potassium SCHEMBL29568431 0.97 CA1 (0.61) CA1CA2MMP1MMP2MMP9
SCHEMBL31120812 0.97 CA1 (0.61) CA1CA2MMP1MMP2MMP9
SCHEMBL6822933 0.97 CA1 (0.61) CA1CA2MMP1MMP2MMP9
SCHEMBL1302465 0.97 CA1 (0.61) CA1CA2MMP1MMP2MMP9
SCHEMBL24036684 0.90 CA1 (0.54) CA1CA2MMP1MMP2MMP9
SCHEMBL5857917 0.90 MMP2 (0.54) CA1CA2MMP1MMP2MMP9
SCHEMBL8564462 0.86 KMT2A (0.66) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116143669-B Amphiphilic organic zinc salt and preparation method and application thereof 华中科技大学 2025-05-09 — — CN claimed
CN-113087689-B Simple synthesis method of 5-amino-gamma-lactone derivative 中国人民解放军空军军医大学 2023-09-29 — — CN claimed
CN-115108874-B Amine azide chiral compound, bis-azide chiral compound and related preparation methods 中国科学院福建物质结构研究所 2023-09-08 — — CN claimed
CN-116143669-A Amphiphilic organic zinc salt and preparation method and application thereof 华中科技大学 2023-05-23 — — CN claimed
CN-113072470-B N-acetonitrile bis-benzenesulfonylimine derivative and preparation method and application thereof 山东师范大学（CN） 2023-01-13 — — CN claimed
CN-115478305-A Preparation method of electrolytic copper foil for high-bending-resistance lithium ion battery and additive thereof 青海电子材料产业发展有限公司 2022-12-16 — — CN claimed
CN-113429407-B Simple synthesis method of 1-alkyl-3-aryl substituted indolizine compound 河南师范大学 2022-12-13 — — CN claimed
CN-115448949-A Synthesis method of chiral allyl phosphine compound 陕西师范大学 2022-12-09 — — CN claimed
CN-115441059-A Multifunctional electrolyte for lithium metal battery and lithium metal battery 徐州纳烯新材料研究院有限公司 2022-12-06 — — CN claimed
US-11298649-B2 Systems and methods incorporating ionic liquids for electrochemically mediated capturing of Lewis acid gases MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-04-12 — — US claimed
EP-1150979-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-11-07 — — EP claimed
US-6291514-B1 Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors 3-DIMENSIONAL PHARMACEUTICALS, INC. 2001-09-18 — — US claimed
WO-2001062737-A2 AMINO PYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF OBESITY AND OTHER DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-08-30 — — WO claimed
WO-2000047578-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 — — WO claimed
EP-0946173-A4 PREPARATION OF 3-FLUORO OXINDOLE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2000-01-05 — — EP claimed
EP-0946173-A1 PREPARATION OF 3-FLUORO OXINDOLE DERIVATIVES Bristol-Myers Squibb Company (US) 1999-10-06 — — EP claimed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 — — US claimed
WO-1998016222-A1 PREPARATION OF 3-FLUORO OXINDOLE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-23 — — WO claimed
EP-0212010-A1 Color developers for pressure-sensitive or heat-sensitive recording papers THE STANDARD REGISTER COMPANY (US) 1987-03-04 — — EP claimed
US-4531139-A Color developers for pressure-sensitive or heat-sensitive recording papers THE STANDARD REGISTER COMPANY (US) 1985-07-23 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11298649-B2 Systems and methods incorporating ionic liquids for electrochemically mediated capturing of Lewis acid gases CA13, CA1, CA12 CA1 2/4885CA2 6/4885MMP1 3249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.